Legal questions swirl around FDA’s new expedited drug program, including who should sign off

FDA staffers and outside experts worry the program runs afoul of legal, ethical and scientific standards used to review new ...
CIDRAP

CIDRAP Op-ed: Vaccine myths that won’t die and how to counter them—part 2

Yesterday we explored four key myths and why they don’t stand up to scrutiny: ‘Vaccines were never properly tested’ ...